Selective androgen receptor modulator and methods of use thereof
US9884038B2 · kind B2 · utility
3Cited by
60References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 8, 2015 |
| Grant date | Feb 6, 2018 |
| Priority date | — |
| Expiry date | Dec 8, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/277
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides substituted acylanilide compounds and uses thereof in treating a variety of diseases or conditions in a subject including, inter alia, a muscle wasting disease and/or disorder such as Duchenne muscular dystrophy or Becker muscular dystrophy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.